Synthesis, Characterization, and Anti-oxidant Evaluation of Novel Coumarin–Pyrazoline Derivatives
Sintesis, Karakterisasi, dan Evaluasi Antioksidan Derivatif Kumarin–Pirazolin Baru
DOI:
https://doi.org/10.21070/ijhsm.v2i1.203Keywords:
Anti-oxidant activity, Coumarin, DPPH assay, Pyrazoline, IC50Abstract
General Background: Oxidative stress is a major contributor to the pathogenesis of chronic diseases such as cancer and cardiovascular disorders. Specific Background: Coumarin and pyrazoline derivatives are known for their pharmacological activities, particularly their antioxidant potential. Knowledge Gap: However, limited studies have explored the synthesis and evaluation of coumarin–pyrazoline hybrids as potent free radical scavengers. Aims: This study aimed to synthesize and characterize novel coumarin–pyrazoline derivatives and evaluate their antioxidant activity using the DPPH assay. Results: Six new compounds were synthesized and structurally confirmed by ¹H-NMR, ¹³C-NMR, and mass spectrometry. Compounds 2 and 5 exhibited superior antioxidant activity compared to ascorbic acid, with IC₅₀ values of 18.3 μM and 19.7 μM, respectively, versus 23.9 μM for ascorbic acid. Novelty: The enhanced activity was attributed to specific functional groups: the methoxy group in compound 2 and the dimethylamino group in compound 5. Implications: These findings support the potential of coumarin–pyrazoline hybrids as promising antioxidant agents and lay the groundwork for future therapeutic development targeting oxidative stress-related conditions.
Highlight :
-
Coumarin–pyrazoline compounds 2 and 5 showed stronger antioxidant activity than ascorbic acid.
-
Structures were confirmed through ¹H NMR, ¹³C NMR, and mass spectrometry.
-
Antioxidant efficiency is linked to specific functional groups like OCH₃ and N(CH₃)₂
Keywords : Anti-oxidant activity, Coumarin, DPPH assay, Pyrazoline, IC50
References
[1] A. R. Verma, M. Vijayakumar, C. S. Mathela, dan C. V. Rao, "In Vitro and In Vivo Antioxidant Properties of Different Fractions of Moringa Oleifera Leaves," Food and Chemical Toxicology, vol. 47, no. 9, pp. 2196–2201, Sep. 2009, doi: 10.1016/j.fct.2009.06.005.
[2] M. N. Alam, N. J. Bristi, dan M. Rafiquzzaman, "Review on In Vivo and In Vitro Methods Evaluation of Antioxidant Activity," Saudi Pharmaceutical Journal, vol. 21, no. 2, pp. 143–152, Apr. 2013, doi: 10.1016/j.jsps.2012.05.002.
[3] F. Soliman, Z. Ismail, N. F. A. El-Ghaffar, N. Dawood, S. H. Abd, dan E. Monem, "Synthesis, Reactivity, Anti-Oxidant and Cytotoxicity Evaluation of Some Coumarin Derivatives," 2018.
[4] B. Parshad dan A. J. Duraisamy, "Synthesis and SAR Study of Antioxidant Potential of Polyhydroxy Coumarin Derivatives," Medicinal Chemistry, vol. 6, no. 7, 2016, doi: 10.4172/2161-0444.1000391.
[5] V. S. V. Satyanarayana, P. Sreevani, A. Sivakumar, dan V. Vijayakumar, "Synthesis and Antimicrobial Activity of New Schiff Bases Containing Coumarin Moiety and Their Spectral Characterization," ARKIVOC, vol. 2008, no. 17, pp. 221–233, Jan. 2009, doi: 10.3998/ark.5550190.0009.h21.
[6] F. Song, X. Huo, dan Z. Guo, "Anti-Breast Cancer Potential of Natural and Synthetic Coumarin Derivatives," Current Topics in Medicinal Chemistry, vol. 21, no. 18, pp. 1692–1709, Mar. 2021, doi: 10.2174/1568026621666210303145430.
[7] Z. Xu, Q. Chen, Y. Zhang, dan C. Liang, "Coumarin-Based Derivatives With Potential Anti-HIV Activity," Fitoterapia, vol. 150, Apr. 2021, doi: 10.1016/j.fitote.2021.104863.
[8] F. Saadati, A. M. Chahardehi, N. Jamshidi, dan D. Ghasemi, "Coumarin: A Natural Solution for Alleviating Inflammatory Disorders," Current Research in Pharmacology and Drug Discovery, vol. 7, p. 100202, Jan. 2024, doi: 10.1016/j.crphar.2024.100202.
[9] N. A. Akwu, M. Lekhooa, D. Deqiang, dan A. O. Aremu, "Antidepressant Effects of Coumarins and Their Derivatives: A Critical Analysis of Research Advances," European Journal of Pharmacology, vol. 956, p. 175958, Oct. 2023, doi: 10.1016/j.ejphar.2023.175958.
[10] A. Rawat dan A. V. B. Reddy, "Recent Advances on Anticancer Activity of Coumarin Derivatives," European Journal of Medicinal Chemistry Reports, vol. 5, p. 100038, Aug. 2022, doi: 10.1016/j.ejmcr.2022.100038.
[11] P. K. Ray, R. Sharma, dan A. Kumar, "Pyrazoline and Pyrazoline Derivatives as Anti-Cancer Agents: Synthesis and Biological Activities: A Compressive Review," Current Topics in Medicinal Chemistry, vol. 25, no. 13, pp. 1548–1612, Jan. 2025, doi: 10.2174/0115680266339816241212081205.
[12] S. Kumar, S. Bawa, S. Drabu, R. Kumar, dan H. Gupta, "Biological Activities of Pyrazoline Derivatives - A Recent Development," Recent Patents on Anti-Infective Drug Discovery, vol. 4, no. 3, pp. 154–163, Sep. 2009, doi: 10.2174/157489109789318569.
[13] S. Sandhu, Y. Bansal, O. Silakari, dan G. Bansal, "Coumarin Hybrids as Novel Therapeutic Agents," Bioorganic and Medicinal Chemistry, vol. 22, no. 15, pp. 3806–3814, Aug. 2014, doi: 10.1016/j.bmc.2014.05.032.
[14] F. Annunziata, C. Pinna, S. Dallavalle, L. Tamborini, dan A. Pinto, "An Overview of Coumarin as a Versatile and Readily Accessible Scaffold With Broad-Ranging Biological Activities," International Journal of Molecular Sciences, vol. 21, no. 13, p. 4618, Jun. 2020, doi: 10.3390/ijms21134618.
[15] I. T. Tchoupou et al., "An Overview of the Synthesis of Coumarins via Knoevenagel Condensation and Their Biological Properties," Results in Chemistry, vol. 15, p. 102181, May 2025, doi: 10.1016/j.rechem.2025.102181.
[16] S. V. Rodriguez, "Synthesis and Trypanocidal Properties of New Coumarin-Chalcone Derivatives," Medicinal Chemistry, vol. 5, no. 4, 2015, doi: 10.4172/2161-0444.1000260.
[17] M. Patel et al., "Coumarin-Carbazole Based Functionalized Pyrazolines: Synthesis, Characterization, Anticancer Investigation and Molecular Docking," RSC Advances, vol. 11, no. 44, pp. 27627–27644, Jul. 2021, doi: 10.1039/d1ra03970a.
[18] G. Çelik, T. Arslan, M. Şentürk, dan D. Ekinci, "Synthesis and Characterization of Some New Pyrazolines and Their Inhibitory Potencies Against Carbonic Anhydrases," Archiv der Pharmazie, vol. 353, no. 3, Mar. 2020, doi: 10.1002/ardp.201900292.
[19] "Microwave Assisted Synthesis, Characterization and Antimicrobial Evaluation of Pyrazolyl and Pyrazoline Substituted Coumarins," [Online]. Available: [https://www.researchgate.net/publication/332697311]
[20] P. Singh, J. S. Negi, G. J. N. Pant, dan M. S. M. Rawat, "5-(3-Nitrophenyl)-3-Phenyl-4,5-Dihydro-1H-Pyrazole-1-Carbaldehyde," Molbank, vol. 2010, no. 1, p. M650, Jan. 2010, doi: 10.3390/m650.
[21] T. Saroja, R. M. Ezhilarasi, V. Selvamani, dan S. Mahalakshmi, "Synthesis, Characterization and In-Silico Analysis of New 2-Pyrazolines," Journal of Scientific Research, vol. 13, no. 1, pp. 183–194, Jan. 2021, doi: 10.3329/jsr.v13i1.46995.
[22] W. A. Eneama, H. H. Salman, dan M. N. Mousa, "Synthesis of a New Isoxazolidine and Evaluation Antitumor Activity In Vitro Against MCF-7 Breast Cancer Cell Line," Oncology and Radiotherapy, vol. 17, no. 11, pp. 1–8, Nov. 2023. [Online]. Available: [https://www.oncologyradiotherapy.com]
[23] M. H. Ahmed, M. A. El-Hashash, M. I. Marzouk, dan A. M. El-Naggar, "Design, Synthesis, and Biological Evaluation of Novel Pyrazole, Oxazole, and Pyridine Derivatives as Potential Anticancer Agents Using Mixed Chalcone," Journal of Heterocyclic Chemistry, vol. 56, no. 1, pp. 114–123, Jan. 2019, doi: 10.1002/jhet.3380.
[24] W. Y. Khalaf, L. A. Raheem, dan R. S. E. Youssef, "Synthesis, Identification, and Biological Evaluation of New Coumarin-Pyrazoline Derivatives as Antioxidant Agents," Baghdad Science Journal, vol. 22, no. 1, pp. 16–35, Jan. 2025, doi: 10.21123/bsj.2024.8978.
[25] A. Z. Al-Saffar et al., "Phytochemical Analysis, Antioxidant and Cytotoxic Potentials of Pelargonium Graveolens Extract in Human Breast Adenocarcinoma (MCF-7) Cell Line," Asian Journal of Biochemistry, vol. 12, no. 1, pp. 16–26, Dec. 2016, doi: 10.3923/ajb.2017.16.26.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Ahmed Kadhim Mohan, Leaqaa Abdulredha Raheem, Maan Abdul-Razzaq Suwaid
This work is licensed under a Creative Commons Attribution 4.0 International License.
